CA2258634A1 - Serine protease inhibitors - Google Patents

Serine protease inhibitors Download PDF

Info

Publication number
CA2258634A1
CA2258634A1 CA002258634A CA2258634A CA2258634A1 CA 2258634 A1 CA2258634 A1 CA 2258634A1 CA 002258634 A CA002258634 A CA 002258634A CA 2258634 A CA2258634 A CA 2258634A CA 2258634 A1 CA2258634 A1 CA 2258634A1
Authority
CA
Canada
Prior art keywords
amino acid
solid phase
group
peptide
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002258634A
Other languages
English (en)
French (fr)
Inventor
Michael Finbarr Scully
Said Elgendy
Vijay Vir Kakkar
Emmanuel Skordalakes
Donovan Green
Christopher Andrew Goodwin
John Joseph Deadman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trigen Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2258634A1 publication Critical patent/CA2258634A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/042General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002258634A 1996-06-29 1997-06-11 Serine protease inhibitors Abandoned CA2258634A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9613719.5A GB9613719D0 (en) 1996-06-29 1996-06-29 Serine protease inhibitors
GB9613719.5 1996-06-29
CN97195991A CN1223664A (zh) 1996-06-29 1997-06-11 丝氨酸蛋白酶抑制剂

Publications (1)

Publication Number Publication Date
CA2258634A1 true CA2258634A1 (en) 1998-01-08

Family

ID=40243006

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002258634A Abandoned CA2258634A1 (en) 1996-06-29 1997-06-11 Serine protease inhibitors

Country Status (9)

Country Link
EP (1) EP0935611A1 (ko)
JP (1) JP2000516202A (ko)
KR (1) KR20000022350A (ko)
CN (1) CN1223664A (ko)
AU (1) AU729393C (ko)
CA (1) CA2258634A1 (ko)
GB (1) GB9613719D0 (ko)
NZ (1) NZ333390A (ko)
WO (1) WO1998000442A1 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0405267D0 (en) * 2004-03-09 2004-04-21 Trigen Ltd Compounds
WO2009042922A2 (en) * 2007-09-27 2009-04-02 Amylin Pharmaceuticals, Inc. Peptide-peptidase inhibitor conjugates and methods of making and using same
EP4045625A1 (en) * 2019-10-18 2022-08-24 Basf Se Storage-stable hydrolase containing liquids

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196404B1 (en) * 1989-08-18 1996-09-10 Biogen Inc Inhibitors of thrombin
US5240913A (en) * 1989-08-18 1993-08-31 Biogen, Inc. Inhibitors of thrombin

Also Published As

Publication number Publication date
GB9613719D0 (en) 1996-08-28
AU729393C (en) 2002-05-16
AU729393B2 (en) 2001-02-01
CN1223664A (zh) 1999-07-21
NZ333390A (en) 1999-11-29
EP0935611A1 (en) 1999-08-18
WO1998000442A1 (en) 1998-01-08
KR20000022350A (ko) 2000-04-25
JP2000516202A (ja) 2000-12-05
AU3042597A (en) 1998-01-21

Similar Documents

Publication Publication Date Title
EP0815139B1 (en) Thrombin inhibitors based on the amino acid sequence of hirudin
EP0482649B1 (en) CM-chitin derivatives and use thereof
EP0267741B1 (en) Peptide compounds
CA2334863C (en) Antithrombotic compounds
EP0106404A2 (en) Peptides
Hofmann et al. Polypeptides. XLIV. Potent synthetic S-peptide antagonists
US4631270A (en) Therapeutically useful pseudopeptides, compositions containing the same and methods of preparation and use
CA2258634A1 (en) Serine protease inhibitors
JP3506274B2 (ja) 新規ペプチドおよび免疫賦活剤
JPH11500433A (ja) セリンプロテアーゼ阻害剤
Radhakrishnan et al. Relief by modification of carboxylate groups of the calcium requirement for the activation of trypsinogen
Elgendy et al. Design of a novel class of bifunctional thrombin inhibitors, synthesised by the first application of peptide boronates in solid phase chemistry
US4058512A (en) Synthetic peptides having growth promoting activity
MXPA98010854A (en) Inhibitors of protease being
JPH05271094A (ja) カルボキシメチル化キチン誘導体を用いる癌転移抑制剤
JP2899415B2 (ja) 血液凝固のカスケードにおいて治療上活性である新規ペプチド誘導体、その製造方法、及びそれらを含有する医薬組成物
JP3465923B2 (ja) 新規ペプチド、それを製造する方法及び用途
US5668109A (en) Peptides for inhibiting pepsin release
EP0722459B1 (en) Hemoregulatory penta- or hexapeptides
CA1180006A (en) Therapeutically useful pseudopeptides, compositions containing the same and methods of preparation and use
CN101177449A (zh) 叉聚肽,其药物组合物与用途
JP3474610B2 (ja) 新規ペプチド、それを製造する方法及び用途
JPH10324700A (ja) 新規抗hiv複合体及び医薬組成物
JPS59161394A (ja) ブレオマイシンの蛋白またはポリペプチド結合体の製造法

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead